(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -5.46%-1.52M | -1.44M |
Payments to suppliers for goods and services | -5.46%-1.52M | ---1.44M |
Operating cash flow | -5.46%-1.52M | ---1.44M |
Investing cash flow | ||
Cash flow from continuing investing activities | -3.58%-3.28M | -3.16M |
Capital expenditure reported | -4.30%-3.29M | ---3.15M |
Net PPE purchase and sale | 79.47%-2.3K | ---11.2K |
Net investment purchase and sale | ---24.96K | ---- |
Interest received (cash flow from investment activities) | 2,319.09%39.92K | --1.65K |
Cash from discontinued investing activities | ||
Investing cash flow | -3.58%-3.28M | ---3.16M |
Financing cash flow | ||
Cash flow from continuing financing activities | -100.28%-26.89K | 9.61M |
Net common stock issuance | ---- | --9.61M |
Net other financing activities | ---26.89K | ---- |
Cash from discontinued financing activities | ||
Financing cash flow | -100.28%-26.89K | --9.61M |
Net cash flow | ||
Beginning cash position | 1,149.86%5.51M | --440.78K |
Current changes in cash | -196.41%-4.82M | --5M |
Effect of exchange rate changes | -93.03%4.5K | --64.48K |
End cash Position | -87.49%689.41K | --5.51M |
Free cash from | -4.46%-4.81M | ---4.61M |
Accounting Standards | US-GAAP | US-GAAP |
No Data